Skip to main content
The BMJ logoLink to The BMJ
. 2002 Mar 2;324(7336):544.

Somatisation in primary care

Solitary disclosure allows people to determine their own dose

James W Pennebaker 1
PMCID: PMC1122455  PMID: 11872562

Editor—On the surface, Schilte et al in their study suggest that disclosure of emotional events has no effect on markers of physical health or health related behaviours—a finding at odds with studies published over the past few years.13 A critical difference between the study by Schilte et al and most other disclosure studies is that Schilte et al required participants to talk about a traumatic experience to another person. Most successful disclosure studies, on the other hand, have had participants write anonymously about a trauma for several days in a laboratory, in a neutral setting, or at home.

The study may help show when disclosure can be helpful versus harmful. It may also address recent controversies surrounding critical incident stress debriefing, where people who have experienced recent trauma are pressed to talk about their emotions to people in the context of a group. An increasing number of controlled tests of techniques wherein people have been asked to talk about emotional upheavals to others have found this form of debriefing either to be unhealthy or to have no effect.4 Having to deal with deeply emotional topics in a social setting forces the listener to help regulate what is and is not said. The social pressure of talking to an “expert” may invite embarrassment or humiliation on the part of the patient. When people are writing or talking into a tape recorder by themselves, they are able to determine how much they are willing to disclose. In short, solitary disclosure allows people to determine their own dose.

Schilte et al suggest that it is not in the physician's or patient's best interest to encourage the deep disclosure of highly traumatic experiences. Separate, equally controlled projects should address whether disclosure in alternative ways (for example, disclosive writing) may bring about the beneficial effects that Schilte et al were originally predicting.

References

  • 1.Schilte AF, Portegijs PJM, Blankenstein AH, van der Horst HE, Latour BF, van Eijk JTM, et al. Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. BMJ. 2001;323:86–91. doi: 10.1136/bmj.323.7304.86. . (14 July.) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Cons Clin Psychol. 1998;66:174–184. doi: 10.1037//0022-006x.66.1.174. [DOI] [PubMed] [Google Scholar]
  • 3.Pennebaker JW, Graybeal A. Patterns of natural language use: disclosure, personality, and social integration. Cur Dir in Psychol Sci. 2001;10:90–93. [Google Scholar]
  • 4.Small R, Lumley J, Donohue L, Potter A, Waldenstrom U. Randomised controlled trial of midwife led debriefing to reduce maternal depression after childbirth. BMJ. 2000;321:1043–1047. doi: 10.1136/bmj.321.7268.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
BMJ. 2002 Mar 2;324(7336):544.

Descriptive use of term should not be confused with its conceptualisation

Antonio L Teixeira Jr 1,2, Henrique Alvarenga-Silva 1,2

Editor—Multiple or unexplained physical symptoms cause substantial disability in patients, excess use of medical services, disappointment for therapists, and frustration for physicians.1-1 Somatisation is used as a descriptive term in somatoform disorders characterised by physical symptoms for which there are no demonstrable organic findings or known physiological mechanisms.1-2

Somatisation is a much broader phenomenon than is reflected in the categories of official diagnostic classifications. The operational definition of somatising patients in the paper by Schilte et al, on the basis of previous studies from Escobar's group, is interesting since most patients with unexplained symptoms do not meet the high threshold of symptoms for somatoform disorder as defined in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV).1-3 The criteria for undifferentiated somatoform disorder are, however, overly inclusive.

Some reasons could be elicited for explaining the absence of effect of the disclosure intervention on the health of somatising patients, including the brief period of intervention and the high prevalence of anxiety and depressive disorders found by Schilte et al. Another possible reason is that different treatment interventions must be designed to treat patients with different levels of distress.1-4 Despite that, somatisation includes a heterogeneous population, and the descriptive use of the term should not be confused with its conceptualisation. Some support the concept of somatisation as the expression of personal distress in an idiom of bodily complaints with medical help seeking behaviour as adopted in the paper, but others have emphasised the need to define the concept clearly, encompassing coping style and personality traits. The effectiveness of treatment strategies derived from such conceptualisations, such as promoting verbal expression of emotions or psychological conflicts in alexithymic patients, has not been shown.1-5 The study by Schilte et al confirms this.

References

  • 1-1.Kroenke K, Spitzer RL, de Gruy FV, Hahn SR, Linzer M, Williams JBW, et al. Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry. 1997;54:352–358. doi: 10.1001/archpsyc.1997.01830160080011. [DOI] [PubMed] [Google Scholar]
  • 1-2.Martin RL, Yutzy SH. Somatoform disorders. In: Hales RE, Yudofsky SC, Talbott JA, editors. The American psychiatric press textbook of psychiatry. Washington, DC: American Psychiatric Press; 1999. pp. 663–710. [Google Scholar]
  • 1-3.Schilte AF, Portegijs PJM, Blankenstein AH, van der Horst HE, Latour BF, van Eijk JTM, et al. Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. BMJ. 2001;323:86–91. doi: 10.1136/bmj.323.7304.86. . (14 July.) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 1-4.Guthrie E. Emotional disorder in chronic illness: psychotherapeutic interventions. Br J Psychiatry. 1996;168:265–273. doi: 10.1192/bjp.168.3.265. [DOI] [PubMed] [Google Scholar]
  • 1-5.Bach M, Bach D, de Zwan M. Independency of alexithymia and somatization. Psychosomatics. 1996;37:451–458. doi: 10.1016/s0033-3182(96)71533-5. [DOI] [PubMed] [Google Scholar]
BMJ. 2002 Mar 2;324(7336):544.

Author's reply

A F Schilte 1

Editor—Pennebaker's theory that written expression is superior to the talking methods applied by us may explain the difference between our negative findings and other positive studies on disclosure. Some other articles on the effect of disclosure through talking did, however, show an effect, although, as Pennebaker points out, this was not as impressive as in written and anonymous disclosure.2-1

Somatisation is an interactive problem. For that reason we chose talking rather than anonymous writing, with the aim of extending the outcome of the talks to the relationship between patient and general practitioner. This may have influenced what patients disclosed. The intervention was offered by us in an open inviting way, reflecting sincere interest in the patient's story and following the patient's frame of reference. Most patients believed that they had disclosed important information and liked the meetings.

We explained our contrasting findings by the difference in the groups of patients studied. Many patients in our study had had problematic childhoods and life stories and were mostly of a lower socioeconomic and educational background. Patterns of healthcare behaviour such as frequent attendance in primary care, a tendency to explain symptoms with a disease model (with external locus of control), a wish to undergo further diagnostic procedures and referrals, and frequent use of symptomatic drugs (painkillers, tranquillisers), physiotherapy, and sick leave are often fixed. Frustration among doctors managing these patients, resulting in patients not being taken seriously and being given a quick prescription or referral, can add further to the somatisation process.2-2

Disclosure through writing or talking can be helpful but does not effectively change the patterns of somatisation, which reflect the healthcare behaviour of patients and their physicians.

Teixeira and Alvarenga-Silva responded to our article from a psychiatric point of view. Somatisation as operationalised by us according to the criteria of Escobar should certainly not be classified as a psychiatric disorder. Most people have episodes with physical complaints that are not explained by organic disease. Low grade somatisation is common, especially in primary care (one in 20 patients) and created at least 20% of the workload of the general practitioners in our study. Effective strategies for somatisation are needed that are not too complex for general practitioners to apply.

An ideal long term disclosure intervention would encompass many contacts with the patient. But patients willing to participate in such long term psychological interventions will visit psychiatrists, psychologists, or social workers, who are better trained. In the Netherlands, most patients, however, are managed by general practitioners, who will usually not be able to find the time for psychological interventions requiring a larger number of contacts.

References

  • 2-1.Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Cons Clin Psychol. 1998;66:174–184. doi: 10.1037//0022-006x.66.1.174. [DOI] [PubMed] [Google Scholar]
  • 2-2.Salmon P, Peters S, Stanly I. Patients' perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ. 1999;318:372–376. doi: 10.1136/bmj.318.7180.372. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES